Previous Page  2 / 12 Next Page
Information
Show Menu
Previous Page 2 / 12 Next Page
Page Background

Page 30

Notes:

Volume 2

Journal of Medical Biotechnology

Biotechnology 2018

July 16-17, 2018

World Biotechnology Congress

July 16-17, 2018 Berlin, Germany

Druggability analysis and classification of bacterial histidine kinase

Mohammad Al Sorkhy

Al Ain University of Science and Technology, UAE

A

nti-Microbial Resistance (AMR) is becoming a real threat to humanity with a resistant strains emerging very frequently. The

arising of antibiotics resistance is mainly attributed to the misuse of these agents, in addition to the decline in the development

of new drugs by the pharmaceutical industry. The development of new novel antibiotics is an emerging necessity to counteract this

serious phenomenon. Bacterial Histidine Kinases (HKs) are one of the most promising targets for novel antibacterial drugs. They are

part of the bacterial Two-Component Systems (TCSs), the main signal transduction pathways in bacteria, regulating various processes

including virulence, secretion systems and antibiotic resistance. Since mammalian histidine kinases signal transduction pathway is

different than the prokaryotic one, the inhibition of those pathways could be a potential target for a novel antimicrobial agent. In

this study, the druggability of histidine kinase will be assessed for several bacterial species. In this work, different histidine kinases

of varies bacterial origins were assed. First we performed some extensive data mining in the Protein Data Bank (PDB) to obtain a

large library of crystal structures of histidine kinases, each one of the proteins were then prepared using the Molecular Operating

Environment software (MOE). Druggability assessment of the prepared histidine kinases was then carried out using SiteMap module

of the Schrödinger molecular modeling suite.

Biography

Mohammad Al sorkhy is an assistant professor of cell and computational biology, Dr Al sorkhy started his career as a cell biologist with interest in protein

interactions. Then he started to shift towards computational biology to answer his major question about protein interactions.

sorakhy@gmail.com

Mohammad Al Sorkhy, J Med Biotechnol 2018, Volume 2